AstraZeneca PLC

15 Minute Delayed Share Price Glossary Go to Portfolio
Current Chg % Chg Open High Low Volume
2,815.50
+35.50
1.28% 2,794.00 2,844.62 2,786.50 6.08m

Share Price Chart

label: share priceshare price chart showing price and earning per share against datelabel: earning per share

Broker Recommendation (11 Brokers)

STRONG SELL STRONG BUY
HOLD
Key Figures
Market Cap. £40,386.14m PER (pr) 7.59x EPS Growth (pr) -1.92% ROCE/ROIC 91.37%
Shares in issue 1452.74m PEG (pr) -3.94f DY (pr) 5.28% Net Gearing 47.5%
Company Background
Sector Health
Activities Pharmaceutical company
TIDM AZN
Index FTSE 100, FTSE 350, S&P Europe 350, Eurotop 300, FTSE Eurotop 100, FTSE All Share
Listed LSE - Full

Outlook

(28/1/2010) PLM: "...the company expects up to a mid single-digit decline in revenue in 2010 on a constant currency basis"
Latest Results
Prelim 31/12/2008 31/12/2009
Turnover £m 21671.24 20288.21
Pre-tax Profit £m 5953.23 6683.78
EPS (Norm Dil.) p 330.89 374.42
Dividend p 95.5 140.8
Notes Figures from 2004 in accordance with IFRS. USD to GBP, 2004: 1.93370, 2005: 1.72030, 2006: 1.96330, 2007: 2.00770, 2008: 1.4582
Investment Ratios
  Co. FTSE Sector Market
PER (pr) x 7.59 10.17 11.02
Dividend Yield (pr) % 5.28 4.97 4.05
PEG (pr) f -3.94 -0.79 -0.40
ROCE % 91.37 53.33 124.67
Operating Margin % 34.21 21.54 9.32
EPS Growth (pr) % -1.92 11.94 16.64
EV/EBITDA x 5.52 7.52 6.94
Net Gearing % 47.52 93.61 150.58
Net Tangible Asset Value PS p -1.09 1.20
Price to Tangible Book Value (PTBV) x -5.37 0.56
Price to Cashflow (PCF) x 11.90 9.70
Price to Sales Ratio (PSR) x 4.71 2.16
Definitions | Disclaimer
Data provided by Morningstar.
© Copyright 2009 Morningstar. All rights reserved. Please read our Terms of Use and Privacy Policy.